Literature DB >> 29201448

Neuroendocrine tumors of the thymus and mediastinum.

Hanibal Bohnenberger1, Helen Dinter1, Alexander König2, Philipp Ströbel1.   

Abstract

Neuroendocrine tumors of the thymus (tNET) and mediastinum are very rare neoplasms with scarce available data. All subtypes [typical and atypical carcinoid tumors (TC and AC), large cell neuroendocrine and small cell carcinoma (SCC)] observed elsewhere in the body occur also in the mediastinum and show only few if any organ-specific morphological differences. Although all available data suggest that the broad principles that govern the biology (and hence) the classification of these tumors in general apply also to tNET, there are a few noteworthy peculiarities related e.g., to risk factors, relative frequency and also to molecular genetic features. In this review, we will briefly summarize current knowledge on tNET with a special emphasis on shared and private features in comparison e.g., with pulmonary NET, which have traditionally been regarded the next closely related NET group.

Entities:  

Keywords:  Thymus; carcinoid tumor; large cell neuroendocrine carcinoma (LCNEC); neuroendocrine; review; small cell carcinoma (SCC)

Year:  2017        PMID: 29201448      PMCID: PMC5690954          DOI: 10.21037/jtd.2017.02.02

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  63 in total

Review 1.  Carcinoid tumors of the thymus.

Authors:  G C Economopoulos; J W Lewis; M W Lee; N A Silverman
Journal:  Ann Thorac Surg       Date:  1990-07       Impact factor: 4.330

2.  Thymic neuroendocrine tumors: a SEER database analysis of 160 patients.

Authors:  Puja Gaur; Colleen Leary; James C Yao
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

3.  Spindle-cell neuroendocrine carcinomas of the thymus (spindle-cell thymic carcinoid): a clinicopathologic and immunohistochemical study of seven cases.

Authors:  C A Moran; S Suster
Journal:  Mod Pathol       Date:  1999-06       Impact factor: 7.842

4.  Pigmented thymic carcinoids: a clinicopathological and immunohistochemical study of two cases.

Authors:  K M Klemm; C A Moran; S Suster
Journal:  Mod Pathol       Date:  1999-10       Impact factor: 7.842

5.  Chromosomal imbalances in sporadic neuroendocrine tumours of the thymus.

Authors:  Ralf J Rieker; Sebastian Aulmann; Roland Penzel; Philipp A Schnabel; Hendrik Blaeker; Irene Esposito; Alicia Morresi-Hauf; Herwart F Otto; Erich Hecker; Hendrik Dienemann; Peter Schirmacher; Gunhild Mechtersheimer
Journal:  Cancer Lett       Date:  2004-12-08       Impact factor: 8.679

6.  Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.

Authors:  R Ullmann; A Schwendel; H Klemen; G Wolf; I Petersen; H H Popper
Journal:  Hum Pathol       Date:  1998-10       Impact factor: 3.466

7.  An ectopic, ACTH producing, oncocytic carcinoid tumor of the thymus: report of a case.

Authors:  I Yamaji; O Iimura; T Mito; S Yoshida; K Shimamoto; T Minase
Journal:  Jpn J Med       Date:  1984-02

8.  Thymic carcinoids in multiple endocrine neoplasia type 1.

Authors:  B T Teh; J Zedenius; S Kytölä; B Skogseid; J Trotter; H Choplin; S Twigg; F Farnebo; S Giraud; D Cameron; B Robinson; A Calender; C Larsson; P Salmela
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

9.  Carcinoid tumor of the thymus with divergent sarcomatoid differentiation: report of a case with histogenetic consideration.

Authors:  T T Kuo
Journal:  Hum Pathol       Date:  1994-03       Impact factor: 3.466

10.  Neuroendocrine carcinoma in a mediastinal teratoma as a rare variant of somatic-type malignancy.

Authors:  Inga-Marie Schaefer; Patrick Zardo; Stefan Freermann; Alexander Marx; Philipp Ströbel; Stefan Fischer
Journal:  Virchows Arch       Date:  2013-08-25       Impact factor: 4.064

View more
  9 in total

1.  Capecitabine and Temozolomide as a Promising Therapy for Advanced Thymic Atypical Carcinoid.

Authors:  Xin Wang; Yuanliang Li; Jianghui Duan; Yingying Chen; Bing Yuan; Zhirong Qi; Huangying Tan
Journal:  Oncologist       Date:  2018-11-09

2.  Diagnostic challenge in diagnosing bilateral breast metastases from mediastinal neuroendocrine tumor: A case report.

Authors:  Kheng Hooi Chan; Chang Haur Lee; Siti Zubaidah Sharif; Firdaus Hayati; Sugunah Sallapan
Journal:  Ann Med Surg (Lond)       Date:  2020-11-11

3.  Unknown primary large-cell neuroendocrine tumor.

Authors:  Sara Póvoa; Daniela Azevedo; Cristiana Marques; Helena Barroca; Andreia Costa
Journal:  Autops Case Rep       Date:  2018-06-08

4.  Anti-Hu Antibody-Associated Adie's Pupil and Paraneoplastic Sensorimotor Polyneuropathy Caused by Primary Mediastinal Small Cell Carcinoma.

Authors:  Lei Zhang; Si Luo; Hui Jin; Xueman Lv; Jiajun Chen
Journal:  Front Neurol       Date:  2019-11-26       Impact factor: 4.003

Review 5.  Genomic alterations in thymoma-molecular pathogenesis?

Authors:  Felicitas Oberndorfer; Leonhard Müllauer
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 3.005

6.  Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.

Authors:  Iina Yliaska; Heikki Tokola; Tapani Ebeling; Outi Kuismin; Olavi Ukkola; Minna L Koivikko; Timo Lesonen; Jussi Rimpiläinen; Tuuli Felin; Eeva Ryhänen; Saara Metso; Camilla Schalin-Jäntti; Pasi Salmela
Journal:  Endocrine       Date:  2022-06-13       Impact factor: 3.925

Review 7.  An overview on the differential diagnostics of tumors of the anterior-superior mediastinum: the pathologist's perspective.

Authors:  Mirella Marino; Stefano Ascani
Journal:  Mediastinum       Date:  2019-02-22

8.  Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population.

Authors:  Zhenhua Li; Jiali Hu; Pifeng Chen; Zhi Zeng
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

9.  Locally advanced primary mediastinal atypical carcinoid successfully resected after neoadjuvant treatment: A case report.

Authors:  Alberto Testori; Vittorio Perfetti; Camilla De Carlo; Paola Bossi; Marco Alloisio; Giuseppe Mangiameli
Journal:  Thorac Cancer       Date:  2021-08-03       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.